Clinical Trial

Lavender Aromatherapy for Preoperative Anxiety in Melanoma and Epithelioma Patients

Study acronym: LAPAM
Completed
View on ClinicalTrials.gov →
Summary
This double-blind, randomized, placebo-controlled trial evaluates whether a single 15-minute session of inhalational lavender aromatherapy, administered preoperatively, reduces anxiety in adult patients (ASA I-II) scheduled for surgical radicalization of pT1a melanoma or epithelioma. Physiological parameters (blood pressure, heart rate, respiratory rate) and validated psychometric scales (DASS-21, STAI Y-1 and Y-2) will be recorded at defined time points before and after the intervention. Total planned enrollment: 66 participants
Trial Details
NCT Number NCT07434323
Lead Sponsor San Gallicano Dermatological Institute IRCCS
Conditions Melanoma, Non-Melanoma Skin Cancer, Preoperative Anxiety, pT1a
Enrollment 66 participants
Start Date 2021-11-02
Primary Completion 2021-12-16 (estimated)
Study Completion 2024-11-02 (estimated)
Updated on ClinicalTrials.gov 2026-02-25